Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“Beginning in 1992, the DEA defined "accepted medical use" based on five criteria, including "adequate safety studies" and "adequate and well-controlled studies proving efficacy."”
UnverifiableConfidence: LOW

Reasoning

The provided evidence from Reason.com cites a GAO report that explicitly mentions the DEA's 1992 definition of "accepted medical use" with the specified criteria. No contradictory information is presented.

On confidence: The claim is directly corroborated by a primary source excerpt stating that the DEA defined "accepted medical use" in 1992 based on five criteria, including "adequate safety studies" and "adequate and well-controlled studies proving efficacy."

Important context

The definition pertains to the DEA's criteria for scheduling drugs under the Controlled Substances Act, as reported in a 2026 article referencing a GAO report.

Evidence

Supporting (2)

  • Tier 1 — Primary source
    Federal drug scheduling relies on vague criteria, GAO report finds

    cannabis illustrates that puzzle. When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of…

  • Tier 1 — Primary source
    Federal drug scheduling relies on vague criteria, GAO report finds

    Drug Policy Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments A GAO report notes that the Controlled Substances Act does not define "potential for abuse" or "accepted medical use." Jacob Sullum | 9.30.2026 12:01 AM…

Limitations

The evidence is limited to a secondary reporting source (Reason.com) summarizing the GAO report; the original GAO document is not directly quoted. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 1, 2026, 4:49 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Reason · Jacob Sullum